Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies - 24/02/23
Doi : 10.1016/j.jaad.2022.09.010
Andrew Blauvelt, MD, MBA a, ⁎ 
, Jacek C. Szepietowski, MD, PhD b, Kim Papp, MD, PhD c, Eric L. Simpson, MD, MCR d, Jonathan I. Silverberg, MD, PhD, MPH e, Brian S. Kim, MD, MTR f, Shawn G. Kwatra, MD g, Michael E. Kuligowski, MD, PhD, MBA h, ∗, May E. Venturanza, MD h, ∗, Shaoceng Wei, PhD i, Leon Kircik, MD f
, Jacek C. Szepietowski, MD, PhD b, Kim Papp, MD, PhD c, Eric L. Simpson, MD, MCR d, Jonathan I. Silverberg, MD, PhD, MPH e, Brian S. Kim, MD, MTR f, Shawn G. Kwatra, MD g, Michael E. Kuligowski, MD, PhD, MBA h, ∗, May E. Venturanza, MD h, ∗, Shaoceng Wei, PhD i, Leon Kircik, MD f a Oregon Medical Research Center, Portland, Oregon
b Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland
c K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada
d Department of Dermatology, Oregon Health & Science University, Portland, Oregon
e Department of Dermatology, George Washington University, Washington, District of Columbia
f Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York
g Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
h Immunology and Autoimmunity, Incyte Corporation, Wilmington, Delaware
i Department of Biostatistics, Incyte Corporation, Wilmington, Delaware
∗Correspondence to: Andrew Blauvelt, MD, MBA, Oregon Medical Research Center, 9495 SW Locust St, Suite G, Portland, OR 97223Oregon Medical Research Center9495 SW Locust St, Suite GPortlandOR97223
| Funding sources: These studies were funded by Incyte Corporation. |
|
| IRB approval status: The study protocols and all amendments were reviewed and approved by the institutional review board at each site. |
|
| Reprints not available from the authors. |
© 2022
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 3
P. 651-653 - mars 2023 Retour au numéro
Article précédent
- Reprint of: Clearance of multiple cutaneous warts by targeting a single lesion: A randomized comparative evaluation of mild local hyperthermia versus cryotherapy
- Rui-Qun Qi, Junfeng Zhou, Bihuan Xiao, Honghui Xu, Shuai Qiao, Peiyao Zhu, Lixin Xia, Yang Yang, Li Zhang, Hongwei Yan, Congcong He, Yuzhe Sun, Xueli Niu, Yuqing Zhang, Lingyu Fu, Xiuli Wang, Hong-Duo Chen, Shanshan Li, Xing-Hua Gao
- Cause or cure? Review of dupilumab and alopecia areata
- Dustin H. Marks, Natasha Mesinkovska, Maryanne M. Senna
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?